NEW YORK (GenomeWeb) – Premaitha Health announced this week that it has signed two distribution deals to make its Iona non-invasive prenatal screening test available in the Middle East. The company's new customers, which it did not name, are establishing three laboratories in the region to act as regional hubs for the Iona test. Premaitha expects the labs to be opened during the second quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Helix customers can purchase apps that interpret different aspects of their genome, Technology Review reports.

The New York Times reports that a number of companies and research institutes are pursuing gene therapies.

Salmon with shorter telomeres survive to make the trip back to their river homes, New Scientist reports.

In PLOS this week: vaginal microbiome composition, population patterns of Chagas-carrying Rhodnius ecuadoriensis, and more.